D-Index & Metrics Best Publications

Giampaolo Merlini

University of Pavia
Italy

Medicine

Italy

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 113 Citations 53,614 762 World Ranking 2816 National Ranking 60

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Italy Leader Award

Overview

What is he best known for?

The fields of study Giampaolo Merlini is best known for:

Gene
Chemotherapy
Enzyme

His studies link Dexamethasone with Internal medicine. In his articles, Giampaolo Merlini combines various disciplines, including Amyloidosis and Cardiac amyloidosis. He regularly ties together related areas like Transthyretin in his Pathology studies. In his research, Giampaolo Merlini performs multidisciplinary study on Transthyretin and Amyloidosis. Many of his studies involve connections with topics such as Monoclonal antibody and Immunology. In his research, Giampaolo Merlini performs multidisciplinary study on Monoclonal antibody and Immunoglobulin light chain. Immunoglobulin light chain and AL amyloidosis are two areas of study in which he engages in interdisciplinary research. AL amyloidosis and Multiple myeloma are two areas of study in which Giampaolo Merlini engages in interdisciplinary research. In his research, Giampaolo Merlini undertakes multidisciplinary study on Multiple myeloma and Bortezomib.

His most cited work include:

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma (2848 citations)
International uniform response criteria for multiple myeloma (2267 citations)
Molecular Mechanisms of Amyloidosis (1568 citations)

What are the main themes of his work throughout his whole career to date

Giampaolo Merlini performs multidisciplinary study in Internal medicine and Intensive care medicine in his work. He incorporates Amyloidosis and Multiple myeloma in his studies. Giampaolo Merlini integrates Multiple myeloma and Bortezomib in his research. His study ties his expertise on Immunology together with the subject of Bortezomib. His AL amyloidosis research extends to Immunology, which is thematically connected. His multidisciplinary approach integrates AL amyloidosis and Amyloidosis in his work. He merges Antibody with Immunoglobulin light chain in his study. In his articles, he combines various disciplines, including Immunoglobulin light chain and Antibody. Pathology connects with themes related to Amyloid (mycology) in his study.

Giampaolo Merlini most often published in these fields:

Internal medicine (66.91%)
Amyloidosis (61.63%)
Immunology (54.68%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

3617 Citations

International uniform response criteria for multiple myeloma

B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade.
Leukemia (2006)

3186 Citations

Molecular mechanisms of amyloidosis.

Giampaolo Merlini;Vittorio Bellotti.
The New England Journal of Medicine (2003)

2121 Citations

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand.
American Journal of Hematology (2005)

1651 Citations

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott.
The New England Journal of Medicine (2018)

1257 Citations

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini.
Circulation (2016)

1152 Citations

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel.
Leukemia (2009)

913 Citations

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis.
The New England Journal of Medicine (2018)

842 Citations

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

R A Kyle;B G M Durie;S V Rajkumar;O Landgren.
Leukemia (2010)

836 Citations

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Giovanni Palladini;Angela Dispenzieri;Morie A. Gertz;Shaji Kumar.
Journal of Clinical Oncology (2012)

774 Citations

If you think any of the details on this page are incorrect, let us know.